In:
Molecular Oncology, Wiley, Vol. 7, No. 3 ( 2013-06), p. 497-512
Kurzfassung:
A rationale for novel therapeutic approaches for the treatment of CNS ATRT is described. Three representative cell lines have been used. In depth analysis of lapatinib with target modulation and target validation assays.
Materialart:
Online-Ressource
ISSN:
1574-7891
,
1878-0261
DOI:
10.1016/j.molonc.2013.01.001
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2013
ZDB Id:
2322586-5